glp 1 parkinson's disease GLP-1 drug may help with disease, study reports Repurposing glucagon-like peptide-1 receptor agonists

For many older adults, its the first opportunity to get GLP-1s, short for glucagon-like peptide-1 receptor agonists, covered by insurance when used strictly for weight loss

Prescriptions are based on patient eligibility, and patient-specific compounding needs

A long-acting release form of exenatide (exenatide ER, Bydureon) was approved by the FDA in 2012, becoming the first once-weekly injection of a GLP-1RA for adults with T2DM [ Table 2 ]

doi: 10.1007/s00296-016-3481-8 95 BinduSMazumderSBandyopadhyayU

Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line

So just keep that in mind that these studies didnt necessarily calculate whether these adverse reactions were statistically significant